Similarities and differences in tumor growth, skeletal remodeling and pain in an osteolytic and osteoblastic model of bone cancer

Kyle G. Halvorson, Molly A. Sevcik, Joseph R. Ghilardi, Thomas J. Rosol, Patrick W Mantyh

Research output: Contribution to journalArticle

68 Citations (Scopus)

Abstract

More than 1.3 million cases of cancer will be diagnosed in 2006 in the United States alone, and 90% of patients with advanced cancer will experience significant, life-altering cancer-induced pain. Bone cancer pain is the most common pain in patients with advanced cancer as most common tumors including breast, prostate, and lung have a remarkable affinity to metastasize to bone. Once tumors metastasize to bone they are a major cause of morbidity and mortality as the tumor induces significant skeletal remodeling, pain and anemia, which reduce the survival and quality of life of the patient. Currently, the factors that drive cancer pain are poorly understood; however, several recently introduced models of cancer pain are not only providing insight into the mechanisms that drive bone cancer pain but are guiding the development of novel mechanism-based therapies to treat the pain and skeletal remodeling that accompanies metatstatic bone cancer. As analgesics can also influence disease progression, findings from these studies may lead to therapies that have the potential to improve the quality of life and survival of patients with skeletal malignancies.

Original languageEnglish (US)
Pages (from-to)587-600
Number of pages14
JournalClinical Journal of Pain
Volume22
Issue number7
DOIs
StatePublished - Sep 2006
Externally publishedYes

Fingerprint

Bone Neoplasms
Pain
Growth
Neoplasms
Quality of Life
Bone and Bones
Survival
Life Change Events
Analgesics
Disease Progression
Anemia
Prostate
Cancer Pain
Breast Neoplasms
Morbidity
Lung
Mortality
Therapeutics

Keywords

  • Bone cancer model
  • Metastasis
  • Nociception
  • Prostate
  • Sarcoma
  • Skeletal malignancies
  • Tumor

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine
  • Clinical Neurology

Cite this

Similarities and differences in tumor growth, skeletal remodeling and pain in an osteolytic and osteoblastic model of bone cancer. / Halvorson, Kyle G.; Sevcik, Molly A.; Ghilardi, Joseph R.; Rosol, Thomas J.; Mantyh, Patrick W.

In: Clinical Journal of Pain, Vol. 22, No. 7, 09.2006, p. 587-600.

Research output: Contribution to journalArticle

Halvorson, Kyle G. ; Sevcik, Molly A. ; Ghilardi, Joseph R. ; Rosol, Thomas J. ; Mantyh, Patrick W. / Similarities and differences in tumor growth, skeletal remodeling and pain in an osteolytic and osteoblastic model of bone cancer. In: Clinical Journal of Pain. 2006 ; Vol. 22, No. 7. pp. 587-600.
@article{1b4c106b624147c79897fa3ff4202e3a,
title = "Similarities and differences in tumor growth, skeletal remodeling and pain in an osteolytic and osteoblastic model of bone cancer",
abstract = "More than 1.3 million cases of cancer will be diagnosed in 2006 in the United States alone, and 90{\%} of patients with advanced cancer will experience significant, life-altering cancer-induced pain. Bone cancer pain is the most common pain in patients with advanced cancer as most common tumors including breast, prostate, and lung have a remarkable affinity to metastasize to bone. Once tumors metastasize to bone they are a major cause of morbidity and mortality as the tumor induces significant skeletal remodeling, pain and anemia, which reduce the survival and quality of life of the patient. Currently, the factors that drive cancer pain are poorly understood; however, several recently introduced models of cancer pain are not only providing insight into the mechanisms that drive bone cancer pain but are guiding the development of novel mechanism-based therapies to treat the pain and skeletal remodeling that accompanies metatstatic bone cancer. As analgesics can also influence disease progression, findings from these studies may lead to therapies that have the potential to improve the quality of life and survival of patients with skeletal malignancies.",
keywords = "Bone cancer model, Metastasis, Nociception, Prostate, Sarcoma, Skeletal malignancies, Tumor",
author = "Halvorson, {Kyle G.} and Sevcik, {Molly A.} and Ghilardi, {Joseph R.} and Rosol, {Thomas J.} and Mantyh, {Patrick W}",
year = "2006",
month = "9",
doi = "10.1097/01.ajp.0000210902.67849.e6",
language = "English (US)",
volume = "22",
pages = "587--600",
journal = "Clinical Journal of Pain",
issn = "0749-8047",
publisher = "Lippincott Williams and Wilkins",
number = "7",

}

TY - JOUR

T1 - Similarities and differences in tumor growth, skeletal remodeling and pain in an osteolytic and osteoblastic model of bone cancer

AU - Halvorson, Kyle G.

AU - Sevcik, Molly A.

AU - Ghilardi, Joseph R.

AU - Rosol, Thomas J.

AU - Mantyh, Patrick W

PY - 2006/9

Y1 - 2006/9

N2 - More than 1.3 million cases of cancer will be diagnosed in 2006 in the United States alone, and 90% of patients with advanced cancer will experience significant, life-altering cancer-induced pain. Bone cancer pain is the most common pain in patients with advanced cancer as most common tumors including breast, prostate, and lung have a remarkable affinity to metastasize to bone. Once tumors metastasize to bone they are a major cause of morbidity and mortality as the tumor induces significant skeletal remodeling, pain and anemia, which reduce the survival and quality of life of the patient. Currently, the factors that drive cancer pain are poorly understood; however, several recently introduced models of cancer pain are not only providing insight into the mechanisms that drive bone cancer pain but are guiding the development of novel mechanism-based therapies to treat the pain and skeletal remodeling that accompanies metatstatic bone cancer. As analgesics can also influence disease progression, findings from these studies may lead to therapies that have the potential to improve the quality of life and survival of patients with skeletal malignancies.

AB - More than 1.3 million cases of cancer will be diagnosed in 2006 in the United States alone, and 90% of patients with advanced cancer will experience significant, life-altering cancer-induced pain. Bone cancer pain is the most common pain in patients with advanced cancer as most common tumors including breast, prostate, and lung have a remarkable affinity to metastasize to bone. Once tumors metastasize to bone they are a major cause of morbidity and mortality as the tumor induces significant skeletal remodeling, pain and anemia, which reduce the survival and quality of life of the patient. Currently, the factors that drive cancer pain are poorly understood; however, several recently introduced models of cancer pain are not only providing insight into the mechanisms that drive bone cancer pain but are guiding the development of novel mechanism-based therapies to treat the pain and skeletal remodeling that accompanies metatstatic bone cancer. As analgesics can also influence disease progression, findings from these studies may lead to therapies that have the potential to improve the quality of life and survival of patients with skeletal malignancies.

KW - Bone cancer model

KW - Metastasis

KW - Nociception

KW - Prostate

KW - Sarcoma

KW - Skeletal malignancies

KW - Tumor

UR - http://www.scopus.com/inward/record.url?scp=33748165207&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748165207&partnerID=8YFLogxK

U2 - 10.1097/01.ajp.0000210902.67849.e6

DO - 10.1097/01.ajp.0000210902.67849.e6

M3 - Article

C2 - 16926574

AN - SCOPUS:33748165207

VL - 22

SP - 587

EP - 600

JO - Clinical Journal of Pain

JF - Clinical Journal of Pain

SN - 0749-8047

IS - 7

ER -